أبحاث الإدراك
ببتيدات عصبية لأبحاث علم الأعصاب. أدناه الدراسات المنشورة لكل مركّب في هذا المجال — 178 دراسة في المجموع، 44 منها منشورة منذ 2023، كلها مرتبطة بسجلها المصدري.
- الإدراكما قبل السريري فقط
Dihexa
Dihexa (PNB-0408; N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small, metabolically stabilised peptide derived from angiotensin IV by the Harding laboratory at Washington State University, reported in animal studies to cross the blood-brain barrier and to act through the hepatocyte growth factor (HGF)/c-Met receptor system. Independent rodent studies reported improved spatial memory and reduced neuroinflammation in APP/PS1 Alzheimer's mice and rescue of working memory after repeated mild brain injury, and a zebrafish study reported hair-cell protection, while a controlled rat study in a Huntington's disease-like model found no protective effect. Several of the developer laboratory's foundational papers, including the 2014 paper linking its procognitive effects to HGF/c-Met, were retracted in 2025, and the paper that introduced dihexa carries an expression of concern. No human study of dihexa has been published; the related HGF/MET modulator fosgonimeton reached a phase 2/3 Alzheimer's trial that did not meet its endpoints.
- دراسات
- 13
- منذ 2023
- 3
- الأحدث
- 2025
- الإدراكسريري مبكر
DSIP
Delta sleep-inducing peptide is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) isolated in 1977 from cerebral venous blood of sleep-induced rabbits. Despite five decades of study, no DSIP gene, precursor protein or receptor has been identified, and the peptide's status as an endogenous sleep factor remains contested. Human work is concentrated in the 1980s and early 1990s and includes small double-blind studies in insomnia, chronic pain and opioid withdrawal with inconsistent results; recent research is almost entirely rodent work on stroke, stress and drug-delivery constructs.
- دراسات
- 36
- منذ 2023
- 1
- الأحدث
- 2024
- الإدراكسريري
Oxytocin
Oxytocin is a nine-amino-acid neuropeptide synthesised in the hypothalamus, with intranasal administration used since the mid-2000s as a research tool for probing social cognition, threat processing and affiliative behaviour in humans. The field is unusually large and unusually contested: early small-sample findings of enhanced trust, emotion recognition and amygdala modulation have been followed by large registered trials and preregistered meta-analyses showing small, heterogeneous and frequently null effects. Current syntheses point to sex-dependent amygdala modulation, a thalamus-striatum-insula circuit as the most reproducible neural signature, and a small significant signal in schizophrenia spectrum disorders. Intranasal delivery to the brain, dose-response and the appropriate outcome measures all remain methodologically unresolved.
- دراسات
- 47
- منذ 2023
- 21
- الأحدث
- 2026
- الإدراكسريري مبكر
Pinealon
Pinealon is the synthetic tripeptide Glu-Asp-Arg (EDR), one of the short peptide bioregulators developed by Khavinson and colleagues at the St Petersburg Institute of Bioregulation and Gerontology. The proposed mechanism is epigenetic: the peptide is described as entering the nucleus and binding specific DNA sequences and histone proteins, thereby modulating expression of genes involved in apoptosis, antioxidant defence and neuroplasticity. The available evidence is almost entirely in vitro or rodent work from this single research group, supplemented by molecular-modelling studies; controlled human data are limited to small Russian occupational and geriatric studies of peptide combinations rather than EDR alone.
- دراسات
- 21
- منذ 2023
- 3
- الأحدث
- 2024
- الإدراكسريري مبكر
Selank
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the immunomodulatory tetrapeptide tuftsin, developed at the Institute of Molecular Genetics in Moscow. Proposed mechanisms include inhibition of enkephalin-degrading enzymes, allosteric modulation of GABA-A receptor signalling, and regulation of BDNF and inflammation-related gene expression. Human data consist of a small number of Russian comparative trials in generalised anxiety disorder and neurasthenia, one placebo-controlled resting-state fMRI study in healthy volunteers, and small Russian and Ukrainian studies in atopic dermatitis, post-COVID asthenia and adjustment disorder published in journals that PubMed does not index. Almost the entire literature originates from a small group of Russian laboratories, and independent Western replication is absent.
- دراسات
- 22
- منذ 2023
- 3
- الأحدث
- 2026
- الإدراكدواء معتمد
Semax
Semax is a synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, consisting of the ACTH(4-7) fragment extended with a C-terminal Pro-Gly-Pro tripeptide that confers resistance to enzymatic degradation. It lacks corticotropic activity and is registered in Russia for ischaemic stroke, optic nerve disease and cognitive indications. Its best-characterised actions are regulation of BDNF and NGF expression and broad transcriptomic modulation of inflammatory and neurosignalling genes in rodent cerebral ischaemia models. Human evidence is dominated by Russian clinical studies of stroke and optic neuropathy, with two small placebo-controlled fMRI studies in healthy volunteers; no regulatory-grade Western trial exists.
- دراسات
- 39
- منذ 2023
- 13
- الأحدث
- 2026
أحدث الأبحاث المنشورة
A systematic review and meta-analysis of oxytocin modulation of amygdala responses to emotional stimuli and implications for anxiolytic effects
Neuroscience and Biobehavioral Reviews · meta-analysis of 55 neuroimaging studies, 3337 participants
PubMed · 41946420Does intranasal oxytocin reduce symptoms of mental disorders? A meta-analysis of clinical trials
Neuroscience and Biobehavioral Reviews · meta-analysis of 42 double-blind randomised controlled trials, pooled N=1922
PubMed · 42134427Effects of exogenous oxytocin on human brain function are regulated by oxytocin gene expression: A meta-analysis of 20 years of oxytocin neuroimaging and transcriptomic analyses
Neuroscience and Biobehavioral Reviews · neuroimaging meta-analysis and transcriptomic analysis across 75 task-fMRI experiments, n=2247
PubMed · 41260504Intranasal Oxytocin and Physical Intimacy for Dermatological Wound Healing and Neuroendocrine Stress: A Randomized Clinical Trial
JAMA Psychiatry · double-blind randomised placebo-controlled trial, 80 heterosexual couples (N=160, mean age 27.6), 7 days twice-daily oxytocin or placebo with suction-blister wounds and 5-day ecological momentary assessment
PubMed · 41222549Intranasal Oxytocin for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled Multisite Trial Assessing Efficacy and Safety
Alcohol, Clinical & Experimental Research · 12-week double-blind placebo-controlled multisite trial, n=100 with alcohol use disorder, up to 70 IU/day intranasal oxytocin
PubMed · 42458234Intranasal oxytocin for alcohol use disorder: A systematic review and multilevel, bayesian, and variance meta-analyses of randomized clinical trial data
Psychoneuroendocrinology · systematic review with multilevel, Bayesian and variance meta-analyses of randomised clinical trial data in alcohol use disorder
PubMed · 42335670Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo-Controlled, Double-Blind, Crossover Study.
Diabetes Obes Metab · randomised placebo-controlled double-blind crossover study, twenty-four adults with obesity (completers), 4.5-hour intravenous oxytocin versus saline infusion before an ad libitum meal
PubMed · 41804830Post-encoding administration of oxytocin selectively enhances memory consolidation of male faces in females
Proceedings of the National Academy of Sciences of the United States of America · three preregistered randomised double-blind placebo-controlled trials, total N=445 (227 male, 218 female), oxytocin given post-encoding, pre-retrieval or pre-encoding
PubMed · 41557801
لأغراض البحث فقط. ليس للاستهلاك البشري أو التشخيص أو العلاج أو الوقاية من أي حالة. لا شيء في هذه الصفحة يعتبر نصيحة طبية.